TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 33 filers reported holding TELA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,344 | -21.0% | 68,168 | 0.0% | 0.11% | -26.8% |
| Q2 2023 | $690,542 | -6.2% | 68,168 | -1.4% | 0.15% | -40.5% |
| Q1 2023 | $735,948 | -23.2% | 69,168 | -17.0% | 0.26% | -29.2% |
| Q4 2022 | $958,732 | +17.1% | 83,368 | -13.3% | 0.36% | +80.6% |
| Q3 2022 | $819,000 | +21.5% | 96,168 | 0.0% | 0.20% | +36.7% |
| Q2 2022 | $674,000 | -44.9% | 96,168 | -8.6% | 0.15% | -38.2% |
| Q1 2022 | $1,223,000 | -10.8% | 105,168 | -1.9% | 0.24% | +0.4% |
| Q4 2021 | $1,371,000 | -6.4% | 107,168 | 0.0% | 0.24% | -10.9% |
| Q3 2021 | $1,464,000 | -24.9% | 107,168 | -11.4% | 0.27% | -29.8% |
| Q2 2021 | $1,950,000 | +6.8% | 121,019 | -1.3% | 0.38% | -1.8% |
| Q1 2021 | $1,826,000 | +7.1% | 122,558 | +8.1% | 0.39% | -0.5% |
| Q4 2020 | $1,705,000 | -36.8% | 113,418 | -30.5% | 0.39% | -47.1% |
| Q3 2020 | $2,698,000 | -21.3% | 163,121 | -38.3% | 0.73% | -56.0% |
| Q2 2020 | $3,427,000 | – | 264,400 | +1337.0% | 1.67% | – |
| Q1 2020 | $0 | – | 18,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,110,709 | $43,737,944 | 25.31% |
| Velan Capital Investment Management LP | 746,087 | $7,938,366 | 6.77% |
| Opaleye Management Inc. | 2,072,813 | $22,054,730 | 6.61% |
| AIGH Capital Management LLC | 1,653,619 | $17,594,506 | 6.48% |
| Worth Venture Partners, LLC | 409,649 | $4,358,665 | 2.13% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 150,775 | $1,604,246 | 1.87% |
| Kamunting Street Capital Management, L.P. | 136,500 | $1,452,360 | 1.85% |
| PERKINS CAPITAL MANAGEMENT INC | 166,500 | $1,772 | 1.67% |
| NEXT CENTURY GROWTH INVESTORS LLC | 777,753 | $8,275,291 | 0.91% |
| Orbimed Advisors | 3,027,542 | $32,213,047 | 0.63% |